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FertilityDuring testis development, proliferation and death of gonocytes are highly regulated to establish a standard
population of adult stem spermatogonia that maintain normal spermatogenesis. As Transforming Growth
Factor beta (TGFbeta) can regulate proliferation and apoptosis, we investigated its expression and functions
during testis development. We show that TGFbeta2 is only expressed in quiescent gonocytes and decreases
gonocyte proliferation in vitro. To study the functions of TGFbeta2, we developed conditional mice that
invalidate the TGFbeta receptor type II in germ cells. Most of the knock-out animals die during fetal life, but
the surviving adults show a reduced pool of spermatogonial stem/progenitor cells and become sterile with
time. Using an organ culture system mimicking in vivo development, we show higher proportions of
proliferating and apoptotic gonocytes from 13.5 dpc until 1 dpp, suggesting a reduction of germinal
quiescence in these animals. Conversely, a 24-hour TGFbeta2-treatment of explanted wild-type testes,
isolated every day from 13.5 dpc until 1 dpp, increased the duration of quiescence.
These data show that the TGFbeta signaling pathway plays a physiological role during testis development by
acting directly as a negative regulator of the fetal and neonatal germ cell proliferation, and indicate that the
TGFbeta signaling pathway might regulate the duration of germ cell quiescence and is necessary to maintain
adult spermatogenesis., route du Panorama, BP6, F-
6 54 99 06.
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During testicular development, the germ lineage passes through
cycles of proliferation and apoptosis. In the mouse, after sexual
differentiation occurring at 11.5 days post-conception (dpc), fetal
male germ cells (named gonocytes) actively proliferate until 16.5 dpc.
Between 16.5 and 19.5 dpc, gonocytes are quiescent, and after birth
they resume mitosis. In parallel, numerous gonocytes during both the
fetal and neonatal phases of proliferation will die by apoptosis,
whereas none of them will die during the quiescent phase (Olaso and
Habert, 2000). These stages are essential for the establishment of a
normal spermatogenesis. After birth, the gonocyte population gives
rise to type A spermatogonia, which will differentiate during
spermatogenesis to produce sperm (de Rooij and Grootegoed, 1998).
This fetal and neonatal period of testis development has been
largely studied in rodents, especially in the rat (Beaumont and Mandl,
1963) (Hilscher et al., 1974) (Boulogne et al., 1999) and mouse(Vergouwen et al., 1991) (Nagano et al., 2000). Nevertheless, the
mechanisms regulating the establishment of the quiescence of germ
cells and resumption of their cell cycle at birth are not yet clear.
Many pathways have been explored and some results suggest
that genes such as Pten, P27, P15 or P53 could be involved in the
germ lineage regulation (Beumer et al., 1999) (Moreno et al., 2001)
(Moreno et al., 2002) (Kimura et al., 2003) (Western et al., 2008).
Because the establishment of normal spermatogenesis is a funda-
mental process, there probably exists a redundancy of several path-
ways to preserve germ cell integrity in case of a defect in the main
regulation system.
One of the pathways known to be involved in cell regulation is the
Transforming Growth Factor beta (TGFbeta) signaling. TGFbeta
(Moses et al., 1981) (Roberts et al., 1981) belongs to a superfamily
of genes including also the bone morphogenetic proteins (BMPs), the
anti-Müllerian hormone (AMH), the growth and differentiation factor
(GDF), the distantly related glial cell line-derived neurotropic factor
(GDNF), the activins / inhibins (Kingsley, 1994), and Nodal (Schier,
2003). TGFbeta signaling controls numerous cellular processes
including cell proliferation, differentiation and apoptosis, both during
embryogenesis and adulthood. Three isoforms of TGFbeta have
been currently described in mammals: TGFbeta1, beta2 and beta3.
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type II (TβRII) receptors serine/threonine kinase on the cell surface
(Derynck, 1994) (Kingsley, 1994). The signal is then transmitted to
the Smad proteins (Attisano and Wrana, 2002). A third type of
TGFbeta receptor (TβRIII), also called betaglycan, has been described
as an accessory receptor, and is known to facilitate the binding of
TGFbeta (especially TGFbeta2) to TβRII (Lopez-Casillas et al., 1993).
TβRII was identiﬁed for the ﬁrst time in 1992 (Lin et al., 1992) and
appears to be the most important signaling receptor (Wrana, 1998).
TGFbeta ligands must bind to TβRII before TβRI is recruited. Once
the holo-complex is formed, the kinase domain from TβRII trans-
phosphorylates the GS domain of TβRI, which in turn phosphorylates
Smad proteins (Lin et al., 2006).
Expression of TGFbeta isoforms and receptors has been described
in the rat during testis development and it was shown that targets of
TGFbeta signaling seem to be Leydig cells and gonocytes (Teerds and
Dorrington, 1993) (Gautier et al., 1994) (Olaso and Habert, 2000).
Additionally to immunohistochemical studies, functional assays
performed in vitro demonstrated a potential effect of TGFbeta on
steroidogenesis, cord formation and gonocyte behavior (Gautier et al.,
1997) (Olaso et al., 1998) (Cupp et al., 1999). Other in vitro data
showed an anti-proliferative effect of TGFbeta1 on mouse primordial
germ cells (PGCs) (Godin andWylie, 1991) (Richards et al., 1999) and
an apoptotic role of TGFbeta on rat fetal and neonatal gonocytes during
the proliferative phases of testis development (Olaso et al., 1998).
Nevertheless, a physiological role of TGFbeta signaling in gonocyte
development has never been demonstrated in vivo. The best way to
establish such a physiological role for TGFbeta signaling would be the
use of transgenic models.
Models of mice lacking TGFbeta isoforms or receptors have been
generated (Dickson et al., 1995) (Oshima et al., 1996) (Sanford et al.,
1997) (Nguyen and Pollard, 2000) (Larsson et al., 2001) (Stenvers
et al., 2003) (Memon et al., 2008). To avoid a probable redundancy
between isoforms, the best way is to disrupt one of the receptors. It is
known that each type II receptor is speciﬁc for its subfamily, unlike
type I receptors. This means that deletion of TβRII would disturb the
TGFbeta signaling only, and not the signaling of the other family
members. Null mutation of TβRII in all cells from early embryonic
stages leads to growth retardation and severe anemia between 10.5
and 12.5 dpc (Oshima et al., 1996). In order to overcome this limita-
tion, we undertook to generate TβRII conditional knock-out mice
(condKO), via the Cre/Lox system, to target the disruption speciﬁcally
in germ cells.
With this model, we demonstrated that TGFbeta signaling in
germ cells is physiologically involved in the regulation of male
gametogenesis as a direct anti-proliferative and anti-apoptotic factor.
This study also showed that TGFbeta might regulate gonocyte
quiescence phase and is fundamental in the initiation and mainte-
nance of adult spermatogenesis.
Materials and methods
Mice
All animal studies were conducted in accordance with the
guidelines for the care and use of laboratory animals of the French
Ministry of Agriculture. Animals were housed under controlled
photoperiod conditions (lights on 08.00-20.00) and were supplied
with commercial feed and tap water ad libitum. Males were caged
with females overnight and the day after mating was counted as
0.5 day post-conception (dpc). Birth occurs at 19.5 dpc, which was
counted as 0 day post-partum (dpp).
The generation of the TβRIIﬂox/ﬂox mice has been previously
described (Chytil et al., 2002).
To knock out TβRII in the PGCs, these ﬂoxed mice (kindly provided
by H. Moses, Vanderbilt University, USA), maintained on a C57BL/6background, were mated with TNAP-Cre mice (kindly provided by A.
Nagy, Samuel Lunenfeld Research Institute, Canada), maintained on a
hybrid 129 Sv/C57BL/6 background. Male TβRII+/ﬂox/TNAP-Cre mice
were then crossed with female TβRIIﬂox/ﬂox mice, as ectopic recom-
binationmay be avoidedwhen the TNAP-Cre locus is transmitted from
the male (Lomeli et al., 2000) (Suzuki et al., 2001).
Genotyping
Animals were genotyped by PCR analysis of genomic DNA from
tail biopsy. To facilitate genotyping of mice, primer pairs were de-
signed for detection of both wild-type (WT) and ﬂoxed (FL) alleles
(8w-a/LA-LoxP: 5’-TAAACAAGGTCCGGAGCCCA-3’ / 5’-ACTTCTG-
CAAGAGGTCCCCT-3’), or for deleted (DEL) allele (8w-a/mSAr: 5’-
TAAACAAGGTCCGGAGCCCA-3’ / 5’-AGAGTGAAGCCGTGGTAGGT-
GAGCTTG-3’) (Chytil et al., 2002). The Cre-speciﬁc primer pair was
as follows: CreForw / CreRev: 5’-GATGCAACGAGTGATGAGGTTCGC-
3’ / 5’-ACCCTGATCCTGGCAATTTCGGC-3’.
Immunohistochemistry
Testes were ﬁxed overnight at 4 °C with Bouin's ﬂuid (2% (w/v)
picric acid, 7% (v/v) formaldehyde, 3.8% (v/v) acetic acid), dehy-
drated and embedded in parafﬁn.
Sections were rehydrated and boiled twice for 5 min in a 10 mM
sodium-citrate solution for antigen retrieval (Shi et al., 1991).
Endogenous peroxidase activity was blocked with 0.3% (v/v) H2O2
in methanol, and non-speciﬁc binding sites were blocked by
incubating the sections with 5% (w/v) bovine serum albumin in
PBS. Subsequently, the slides were incubated overnight at 4 °C with
the following primary antibodies: anti-TGFβ1 (1:50; sc-146, Santa-
Cruz Biotechnology Inc., Santa Cruz, CA); anti-TGFβ2 (1:50; # 905-
582, Assay Designs); anti-TGFβ3 (1:200; sc-82, SantaCruz Biotech-
nology Inc.); anti-TβRI (1:50; sc-398, SantaCruz Biotechnology Inc.);
anti-TβRII (1:50; sc-220, SantaCruz Biotechnology Inc.), anti-TNAP
(1:50; sc-23430, Santa Cruz Biotechnology Inc.), and anti-PLZF (1:50;
sc-22839, Santa Cruz Biotechnology Inc.). After washing in PBS, slides
were incubated at room temperature with a secondary biotinylated
antibody (ABC peroxidase staining kit; Vector Laboratories Inc.,
Burlingame, CA) diluted 1:200. The avidin-biotin complex reaction
was performed according to the manufacturer's protocol. To visualize
bound antibodies, sections were covered with 3, 3’-diaminobenzidine
(DAB; substrate kit for peroxidase, Vector Laboratories Inc.). Negative
control sections were treated as described above, except that primary
antibody was omitted during the procedure and replaced by 5%
bovine serum albumin in PBS.
Organotypic cultures
Mouse fetal testes were cultured on Millicell CM (Fischer Scientiﬁc
Labosi, Elancourt, France) ﬁlters (pore size 0.4 mm) as previously
described (Livera et al., 2006). Testes from embryos were collected at
13.5 dpc and the mesonephros was removed. Brieﬂy, for each animal,
each testis was placed on a ﬁlter ﬂoating on medium in tissue-culture
dishes and incubated at 37 °C in a humidiﬁed atmosphere containing
95% air and 5% CO2. The culture medium used was a mix of Dulbecco's
modiﬁed Eagle's medium (DMEM) and Nutrient Mixture F-12 Ham's
(HAM'sF12) (1:1) (Gibco, Cergy Pontoise, France). No serum, hormone
or growth factorwas added to themedium. Testeswere cultured for one
day (corresponding to 14.5 dpc in vivo), four days (corresponding to
17.5 dpc in vivo), six days (corresponding to 0 dpp in vivo), or sevendays
(corresponding to 1 dpp in vivo).
To measure testicular responsiveness to TGFβ, tissue-culture dishes
had been previously siliconed with Sigmacote (Sigma-Aldrich Lyon,
France) to avoid TGFβ binding to the plastic dishes. One testis was
cultured for 24 hours in a control medium and the contra-lateral testis
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Systems Europe, France).
Proliferation and quiescence study
In vivo: pregnant females at 13.5 dpc were injected intra-
peritoneally with 5-bromo–2’-deoxyuridine (BrdU, Sigma-Aldrich,
France) at a dose of 50 mg per kilogram body-weight (Merlet et al.,
2007). Fetuses were sacriﬁced 3 hours later and testes were ﬁxed
overnight at 4 °C in a 4% (w/v) paraformaldehyde-PBS solution.
In vitro: testes were incubated at the end of the culture period for 3
hours, with 10 µg/ml BrdU added to the culture medium. Then, testes
were ﬁxed overnight at 4 °C with a 4% (w/v) paraformaldehyde-PBS
solution.
Incorporated BrdU was revealed by immunohistochemistry with a
BrdU/AMH (Anti-Müllerian Hormone) double-staining, as previously
described (Merlet et al., 2007). Brieﬂy, the AMH staining will color
purple the cytoplasm of all the Sertoli cells, making easier the
recognition of germ cells, which keep a colorless cytoplasm.
The phosphorylated form of the histone H3 (P-H3) was detected
by immunohistochemistry (phospho-H3 #9701, 1:100, Cell Signaling
Technology).
The proportion of quiescent germ cells was quantiﬁed after Ki67
staining (anti-Ki67 antibody, # 550609, 1:50, BD Pharmingen). Ki67-
negative gonocytes were considered quiescent.
The percentage of proliferating or quiescent germ cells was
determined in fetuses and newborns by counting at least 1000 cells
and in adults by counting cells in 100 round tubule sections.
Apoptosis detection
Apoptosis was detected by immunostaining for the cleaved-
caspase3 and by using the ApopTag In Situ Apoptosis Detection Kit
(ISEL method; S7100-KIT, MP Biomedicals, Illkirch, France), as
previously described (Duan et al., 2003).
Testicular single cell suspension
Cells were isolated from 4-month-old male mice as previously
described (Lassalle et al., 2004). Brieﬂy, the seminiferous tubules were
enzymatically dissociated for 20 min at 32 °C with collagenase type I
(Invitrogen) at 100 U/ml in Hanks’ balanced salt solution (HBSS)
supplemented with 20 mM HEPES pH 7.2, 1.2 mM MgSO47H2O,
1.3 mM CaCl22H2O, 6.6 mM sodium pyruvate (Invitrogen), 0.05%
lactate (Sigma-Aldrich, France). To discard interstitial cells, the
suspension was ﬁltered through a 40 µm nylon mesh and the tubules
were recovered on the ﬁlter to be incubated in a Cell Dissociation
Buffer (Invitrogen) for 25 min at 32 °C. The resulting cell suspension
was ﬁltered through a 40 µm nylon mesh to remove cell clumps. After
an HBSS wash, the cell pellet was resuspended in the incubation
buffer (HBSS supplemented with 20 mM HEPES pH 7.2, 1.2 mM
MgSO47H2O, 1.3 mM CaCl22H2O, 6.6 mM sodium pyruvate, 0.05%
lactate, 2 mM L-glutamine and 1% decomplemented fetal calf serum)
and further incubated at 32 °C. Cell concentrations were estimated
using Trypan Blue (N95% viable cells).
Flow cytometry analysis
As previously described (Barroca et al., 2009), 106 cells were
stained with Hoechst 33342 (5 µg in 1 ml incubation buffer) for
50 min at 32 °C. Cells were then labeled for 20 min at 4 °C with
monoclonal antibodies or corresponding isotypes (1 µg per 106 cells):
anti-c-kit-APC and anti-α6 integrin-PE (BD Pharmingen). After
washing, cells were resuspended in incubation buffer with 2 µg/ml
propidium iodide (to exclude dead cells) and maintained at room
temperature before analysis with a LSR II ﬂow cytometer (BectonDickinson). Elongated spermatids were excluded to avoid any
contamination of the germinal side population (SP).
Statistics
All values are means±SEM. The signiﬁcance of the differences
between mean values was evaluated by the Student t-test (Instat3,
GraphPad software). A pb0.05 was considered signiﬁcant and
illustrated with one asterisk.
Results
Expression of TGFbeta isoforms and receptors in mouse testis during
development
Expression of the TGFbeta isoforms and receptors type I and type II
was studied by immunohistochemistry during testis development
(Fig. 1 and S1). Whereas the receptors were both expressed throughout
testis development in germ and Leydig cells (Figs. 1A, B and S1), the
three TGFbeta isoformswere expresseddifferently duringdevelopment.
TGFbeta1 could not be detected in testis (Figs. 1D, G and J) and TGFbeta3
was expressed in both gonocytes and Leydig cells at all studied stages of
testis development (Figs. 1F, I and L). TGFbeta2 was the only TGFbeta
isoform expressed differently according to the gonocyte proliferation
status. During fetal and neonatal phases of gonocyte proliferation,
TGFbeta2 was detected in Leydig cells and only in some gonocytes
(Figs. 1E and K), whereas during the quiescent phase it is expressed in
Leydig cells and all gonocytes (Fig. 1H). The proportion of Ki67-negative
gonocytes (G0-phase) was determined at 13.5 dpc, 16.5 dpc and 2 dpp,
and compared to the proportion of TGFbeta2-positive gonocytes
(Fig. 1M): no signiﬁcant difference was observed at the three stages.
These results suggested that the TGFbeta signaling pathway might be
involved in the control of gonocyte proliferation.
TGFbeta signaling pathway regulates both gonocyte proliferation and
death in vitro
Wild-type testes were explanted at 13.5 dpc and cultured for 24 h
with or without TGFbeta2. TGFbeta2 treatment resulted in a three-
fold decrease of gonocyte proliferation, measured by BrdU/AMH
double-staining (Figs. 2A, B and C), and in a four-fold decrease of
dying gonocytes, measured using cleaved caspase 3/AMH double-
staining (Figs. 2D, E and F) or an ISEL assay (data not shown). These
results indicated that in vitro the TGFbeta signaling pathway regulated
both proliferation and death of gonocytes and prompted us to study
the role of TGFbeta during testis development.
Generation and characterization of the TβRII -/ﬂox/TNAP-Cre mice
To suppress speciﬁcally in germ cells the TGFbeta signaling
pathway activated by TGFbeta but not by the other members of the
TGFbeta superfamily, we crossed mice harboring a ﬂoxed TGFbeta
receptor type II (TβRII) gene and TNAP-Cre mice that have been shown
to express the Cre recombinase in germ cells during testis develop-
ment. After mating TβRII+/ﬂox/TNAP-Cre and TβRIIﬂox/ﬂox mice, we
obtained 170 newborns, but only 4% of TβRII -/ﬂox/TNAP-Cre mice
(condKO) instead of the 25% expected for Mendelian transmission.
This abnormal percentage indicated that the majority of condKO
animals unexpectedly died in utero in spite of the germ cell-targeted
deletion of TβRII. To determine when lethality occurs, female mice
were sacriﬁced at different stages of pregnancy. At 14.5 dpc, from a
total of 37 embryos, 24 were alive, 3 had no beating heart and 10 were
aborted embryos. Genotyping of the 24 living embryos showed that
only one was a condKO. The 3 embryos without beating heart were all
condKO, indicating that the lethality occurred around this stage of
development. This was conﬁrmed by genotyping 214 embryos at 13.5
Fig. 1. Expression of TGFbeta receptors type I (A) and type II (B) and isoforms TGFbeta1 (D, G, J), TGFbeta2 (E, H, K) and TGFbeta3 (F, I, L) during mouse testis development.
Immunostaining for both receptors was performed at 18.5 dpc (A-B) and for the different isoforms at 13.5 dpc (D-F) during the fetal phase of germinal proliferation, at 16.5 dpc (G-I)
during the quiescent phase of germ cells and at 2 dpp (J-L) during the neonatal phase of germinal proliferation. A negative control is illustrated in C. Proportions of Ki67-negative
gonocytes and TGFbeta2-positive gonocytes were quantiﬁed and compared at 13.5 dpc, 16.5 dpc and 2 dpp (M). Black arrow: positive germ cell; white arrow: negative germ cell; lc:
Leydig cells. Bars represent 10 µm.
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that death of condKO occurs between 13.5 dpc and 14.5 dpc. At 13.5
dpc, the condKO embryos displayed 3 distinct phenotypes: a normal
one (N) (37.5% of total condKO) (Fig. S2B) quite similar to a WT
embryo (Fig. S2A), an intermediate one (I) (14.6% of total condKO)
(Fig. S2C) and a severe one (S) (47.9% of total condKO) (Fig. S2D).
Compared with 13.5 day-old WT embryos, the (I) and (S) condKO
embryos had the same size but looked anemic. The most severely
disturbed phenotype (S) showed brain bleeding and a small
hemorrhagic liver. TNAP immunohistochemical staining on sagittal
sections of entire 10.5 dpc embryos and in 13.5 dpc placental sections
showed that TNAPwas not speciﬁc to germ cells, but was also strongly
expressed in cardiac cells and in placenta (Fig. S3), which both
strongly expressed TβRII (data not shown). This indicated that the
TNAP-Cre-mediated deletion of TβRII might also occur in the heart
and placenta additionally to germ cells, and could explain the
observed embryonic lethality.The TGFbeta signaling pathway regulates gonocyte proliferation during
development
As condKO embryos were alive at 13.5 dpc, we analyzed the
deletion of TβRII in their germ cells by immunohistochemistry and
showed that the TβRII was no longer expressed in the condKO germ
cells (data not shown). Proliferation of condKO and control littermate
gonocytes was compared by BrdU incorporation in vivo at 13.5 dpc
and 1 dpp (fetal and neonatal proliferation phases) and in vitro after
testis explantation at 13.5 dpc followed by 1 day, 4 days, 6 days and
7 days of organotypic culture (Fig. 3A). In vivo at 13.5 dpc and in vitro
after 1 day of culture, the percentage of gonocytes that incorporate
BrdU was almost doubled in condKO compared with control. After
4 days of culture (which corresponds in vivo to the quiescent phase),
quiescence was observed both in control and condKO testes. After 6
and 7 days of culture (corresponding in vivo to the neonatal prolif-
eration phase), a two-fold higher proportion of condKO gonocytes had
Fig. 2. TGFbeta2 decreased gonocyte proliferation and apoptosis in vitro. The proliferation level of germ cells (BrdU incorporation) wasmeasured in wild-type (WT) testes, explanted
at 13.5 dpc and cultured for 24 h with or without 5 ng/ml TGFbeta2 (A). BrdU/AMH double-staining was used to count the proliferating germ cells in control (B) and TGFbeta2-
treated (C) testes. Nuclei of cells positive for BrdU are stained brown, and the cytoplasm of Sertoli cells, positive for AMH, is colored purple. Counterstaining of all the nuclei was
performedwith hematoxylin (blue). Proliferating germ cells have a brown nucleus andwhite cytoplasm (black arrowhead), and non-proliferating germ cells have a blue nucleus and
white cytoplasm (white arrowhead). Bars represent 10 µm. The apoptotic level of gonocytes was also measured in WT testes, explanted at 13.5 dpc and cultured for 24 h with or
without 5 ng/ml TGFbeta2 (D). Cleaved caspase 3/AMH double-staining was used to count the apoptotic germ cells in control (E) and TGFbeta2-treated (F) testes. Apoptotic
gonocytes are stained brown (arrows). Bar represents 10 µm. Signiﬁcance is illustrated with an asterisk.
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also found in vivo in one condKO male that was alive after birth.
Then, we compared the proportion of gonocytes in the different
phases of the cell cycle in condKO and control littermatemice at 13.5 dpc
and found, in condKO, a decreased number of gonocytes in G0 (Fig. 3Ba;
Bb-Bc), an increased number of gonocytes in S-phase (Fig. 3Ba; Bd-Be)
and a reduced number of gonocytes in G2/M (Fig. 3Ba; Bf-Bg).
Finally, we studied in vitro the impact of a TGFbeta2-treatment on
gonocyte quiescence. Gonocytes from WT testes explanted every day
from 13.5 dpc to 1 dpp and culturedwith or without TGFbeta2 for 24 h
were counted using Ki67/AMH double-staining (Fig. 4). In control
testes, the “quiescent phase” (100% of gonocytes are Ki67-negative)
occurred between15.5 dpc+24 h and17.5 dpc+24 h. After TGFbeta2
treatment, proportion of Ki67-negative gonocytes reached 98% at 14.5
dpc +24 h and 99.6% at 18.5 dpc +24 h, indicating that more
gonocytes have entered the “quiescence phase” one day before and
one day after the classical period.
These results suggested that TGFbeta negatively regulates fetal and
neonatal gonocyte proliferation. Inactivation of TGFbeta signaling did
not completely suppress the period during which 100% of gonocytes
are quiescent, but increased the gonocyte proliferation before and
after this period. In contrast, addition of exogenous TGFbeta2 on WT
testes induced the quiescence of more than 98% of gonocytes, both
one day before and one day after the classical quiescence phase.
The TGFbeta signaling pathway regulates gonocyte death during
development
As the number of gonocytes is strongly dependent on proliferation
but also on cell death during testis developmentwe studied the role of
the TGFbeta signaling pathway in the death of gonocytes. At 13.5 dpc,
the percentage of apoptotic gonocytes was increased two-fold in
condKO mice compared with control littermates (Fig. 5A). This
difference could not be evidenced after 4 days of culture, i.e. during
the gonocyte quiescent phase, but was observed again after 6 and
7 days of culture i.e. when gonocytes re-enter the cycle. In vivo, at 1
dpp, we also found a three-fold increase of apoptotic cells in condKO
gonocytes. A similar result was also obtained in vivo at 13.5 dpc using
the ISEL method (Fig. 5B). These results seemed speciﬁc to the role of
the TGFbeta in gonocytes and not due to side effects related to the
condKO phenotype, as we found similar percentages of both apoptotic
and proliferating germ cells in N-condKO and S-condKO testes at 13.5
dpc (Fig. S5). Altogether, these results indicated that the TGFbetasignaling pathway negatively regulated both proliferation and
apoptosis of gonocytes during development.
Phenotype of adult TβRII -/ﬂox/TNAP-Cre mouse spermatogenesis
In spite of the early death of most of the TβRII conditional KOmice,
two males survived until adulthood. By mating them with wild-type
female mice, fertility of one male was studied between the age of 3
and 4 months, and fertility of the second onewas studied from the age
of 3 months onwards (Fig. 6A). Whereas the mean number of pups
per litter remained fairly constant for wild-type males aged from 3 to
9 months, this number showed a progressive age-related decrease for
the older condKOmale, since it became totally infertile after 8 months.
The efﬁciency of the TβRII deletion in germ cells was demonstrated by
(i) immunohistochemical study of TβRII on condKO testis that showed
that expression was absent speciﬁcally in germ cells, whereas the
Leydig cells still express the receptor (Fig. S4), and (ii) by genotyping
the condKO offspring which was 100% heterozygous.
These two condKO males were sacriﬁced at 4 or 9 months to
characterize their testis abnormalities. Histological study showed an
abnormal morphology of the 4 month-old condKO testis with some
tubules being completely depleted in germ cells and some others
being totally disorganized (Fig. 6B). Additionally, the number of
TUNEL-positive germ cells was increased in condKO (data not shown).
This phenotype became extremely severe at 9 months with no normal
tubules in condKO testis. No spermatozoa could be detected and the
interstitial tissue was more abundant compared with WT.
In order to determine the step of impairment, we performed a ﬂow
cytometry analysis in one WT and one condKO adults at the age of
4 months. We analyzed the population of germinal stem cells and
spermatogonial progenitors, which was shown to harbor the side
population (SP) phenotype, based on the Hoechst 33342 efﬂux
(Lassalle et al., 2004) (Falciatori et al., 2004). CondKO displays a
smaller SP thanWT (9.2% versus 13.4%) (Figs. 7A and C). Additionally,
on the gated SP, the α6-integrin and c-Kit labeling showed a slight
reduction of the SP/α6+/c-Kit-/low population (As to Aal spermatogonia
corresponding to stem cells and immature progenitors) in condKO
comparedwithWT (15.1% versus 17.6%) (Figs. 7B and D). The reduced
SP population combined with the reduced SP/α6+/c-Kit-/low sub-
population suggested a 41%-reduced population of germ stem cells
and immature progenitors in the 4 month-old condKO.
In agreement with the FACS results, immunostaining for PLZF, a
speciﬁc marker of stem/immature progenitor cells (c-Kit-/low
Fig. 3. Inactivation of the TGFbeta pathway increases the proportion of gonocytes in S-phase and decreases the proportion of gonocytes in G0 and G2/M. (A) The proliferation level of
gonocytes was measured in condKO and littermate control testes, by determining the proportion of cells that incorporated BrdU. This study was performed in vivo at 13.5 dpc and 1
dpp, and after culture for 1, 4, 6 or 7 days. The number of cases is noted in brackets. Signiﬁcance is illustrated with an asterisk. (Ba) The proportion of gonocytes in G0, S, and G2/M
was determined in condKO and littermate control testes at 13.5 dpc. The G0-phase was measured after Ki67/AMH double-staining (Bb-Bc): gonocytes in G0 are Ki67-negative
(arrowhead); The S-phase was measured after BrdU/AMH double-staining (Bd-Be); The G2/M-phases were measured after P-H3/AMH double-staining (Bf-Bg). Signiﬁcance is
illustrated with an asterisk.
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positive cells was reduced by 35% in the condKO compared with the
WT (Fig. 7E). Finally, we performed PLZF/Ki67 double-staining to
study the proportion of cycling stem/ immature progenitor cells.
Whereas around 30% of stem/immature progenitor cells were cycling
in WT testes, only 5 to 10% of these cells were cycling in condKO
(Figs. 7F–G).
All these data suggest that normal adult spermatogenesis is
dependent on functional TGFbeta signaling in developing germ cells.
Discussion
During fetal and neonatal life, development of gonocytes is critical
for the establishment of adult spermatogenesis. Involvement of the
TGFbeta superfamily during gametogenesis has been largely investi-
gated in drosophila (Kawase et al., 2004) (Li et al., 2007) and rodents.
Numerous studies have revealed the critical role of several membersof this family, particularly BMPs (Ross et al., 2007; Zhao et al., 1996;
Zhao et al., 1998), in the initiation and maintenance of male and
female gametogenesis. The present study demonstrates that TGFbeta
is physiologically involved in the development of mouse germ cells,
particularly during their quiescent period, and in the maintenance of
adult spermatogenesis. The Cre/Lox system allowed us to demon-
strate that TGFbeta acts directly on gonocytes, in accordance with the
immunolocalization of TGFbeta isoforms and receptors.
The TNAP-Cre model induces a speciﬁc gene deletion in the germ
line as early as the PGC stage as described by Lomeli et al. on a 129/SvJ
background (Lomeli et al., 2000). Several teams have already used it
successfully (Kimura et al., 2003) (Kaneda et al., 2004) (Kehler et al.,
2004). Although it is known that TNAP expression is not restricted to
the PGCs and gonocytes (MacGregor et al., 1995), all these conditional
knock-out models survived until adulthood.
In our model, the ectopic excision of the TβRII gene led to
embryonic lethality of the majority of condKOmice. We observed that
Fig. 4. TGFbeta2 can increase the duration of the germinal quiescence. The proportion of quiescent gonocytes (Ki67-negative) was determined inWT testes, explanted from 13.5 dpc
to 1 dpp, and cultured for 24 h with or without TGFbeta2 (5 ng/ml). The number of cases is noted in brackets. Signiﬁcance is illustrated with an asterisk.
80 S.G. Moreno et al. / Developmental Biology 342 (2010) 74–84TNAP is importantly expressed in fetal cardiac cells, in placental cells
and in the umbilical cord. As the cardiac and placental tissues express
the TGFbeta isoforms and receptors (Roelen et al., 1994), the TβRII
deletion in these tissues is probably responsible for the mouse
lethality. Thus, our study demonstrates the limits of the TNAP-Cre
model.
TGFbeta is known to negatively regulate cell proliferation in
different systems. It acts through different signaling pathways
including the cyclin inhibitor p27. Recently, Western et al (Western
et al., 2008) have reported that gonocyte mitotic arrest is probably
mediated by preventing pRb phosphorylation through the activation
of P27. However, the factors involved upstream of this signaling
cascade have not been elucidated yet. In mouse, in vitro studies have
described an anti-proliferative effect of TGFbeta on PGCs during their
migration to the gonads between 8.5 and 11.5 dpc (Godin and Wylie,
1991) (Richards et al., 1999). In this paper, we showed, both in vitro
and in vivo, that TGFbeta2 also inhibits gonocyte proliferation at 13.5
dpc and later on. In vitro, addition of exogenous TGFbeta2 led to a
signiﬁcant decrease of the level of BrdU-positive gonocytes, associated
with a signiﬁcant increase of the quiescent gonocyte proportion. By
contrast, the in vivo germ-speciﬁc disruption of the TGFbeta signaling
pathway increased the level of cycling gonocytes and revealed a direct
anti-proliferative effect of TGFbeta on germ cells.Fig. 5. Inactivation of the TGFbeta pathway increases the level of apoptotic gonocytes. The
determining the proportion of cleaved caspase3-positive cells. This study was performed in
methodwas used at 13.5 dpc in vivo to conﬁrm the results obtainedwith the cleaved caspase3
asterisk.In addition, our data suggest that TGFbeta regulates also the
gonocyte quiescence. Gonocytes do not enter synchronously into
quiescence, but the “quiescent phase” is deﬁned as the time period
during which 100% of gonocytes are quiescent. In our WT mice, 100%
of gonocytes are quiescent between 16.5 and 18.5 dpc, but at 13.5 dpc,
30% of them are already in G0. When TβRII is disrupted in germ cells,
the “quiescent phase” is not completely abolished, but only 20% of
gonocytes are quiescent at 13.5 dpc, and the proportion of gonocytes
in S-phase is at least two-fold higher before and after the “quiescent
phase”. More precisely, the proportion of proliferating gonocytes at
13.5 dpc+6d in condKO is equivalent to that observed in WT one day
later. These observations may simply reﬂect the regulating role of
TGFbeta on both fetal and neonatal proliferation of gonocytes outside
the “quiescent phase”. Nevertheless, these results may be consistent
with several other hypotheses involving directly TGFbeta in the
control of the “quiescence phase”, by regulating, (i) either the
individual gonocyte quiescence, (ii) or all the phases of the gonocyte
cell cycle. A combination of these two possibilities is also probable.
The fact that the “quiescence phase” is not completely aborted in
condKO mice might be due, either to a redundancy between TGFbeta
and one or several members of its superfamily such as, for example,
activin, or to a redundancy with another signaling pathway. Activin is
expressed in rat gonocytes during their quiescence (Meehan et al.,level of apoptotic gonocytes was measured in condKO and littermate control mice, by
vivo at 13.5 dpc and 1 dpp, and after organotypic culture for 4, 6 or 7 days (A). The ISEL
staining (B). The number of cases is noted in brackets. Signiﬁcance is illustrated with an
Fig. 6. Spermatogenesis is impaired in adult condKO mice. (A) After breeding with WT females, fertility of WT and condKO males was studied between 3 and 9 months of age. The
number of litters is noted in brackets. (B) Histology of testes was studied after hematoxylin/eosin staining, in 4 and 9 month-old condKO mice and compared with WT adult mice.
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IIB) (Itman et al., 2006). Thus, in the absence of TβRII in germ cells,
TGFbeta could bind ActRIIA/IIB and induce a cell cycle arrest by
activating the activin signaling pathway. A second hypothesis is that
TGFbeta and Activin regulate the quiescence phase together.
Even if a quiescent period still exists in the condKO mice, the
reduction of its duration could probably be involved in the
impairment of adult spermatogenesis. Kimura et al (2003) suggested
that quiescence was a critical event in the establishment of male germ
cell commitment. They reported that gonocytes lacking Pten do not
enter quiescence, leading to bilateral testicular teratoma in adult. In
our model, we can suppose that the absence of TGFbeta signaling in
gonocytes prevents the activation of the Pten/Akt pathway, leading to
higher germinal proliferation. This would be in agreement with
ﬁndings, which have demonstrated the involvement of the Pten/Akt
pathway in a TGFbeta-induced inhibition of lung endothelial cell
proliferation (Xing et al., 2008).
Additionally to an anti-proliferating effect, we showed here that
TGFbeta has an anti-apoptotic effect on gonocytes. TGFbeta has been
previously described as an inducer of gonocyte apoptosis in fetal rat
testis in vitro (Olaso et al., 1998). In contrast, here we demonstrate,
both in vitro and in vivo, that TGFbeta is a negative regulator of
gonocyte apoptosis in mouse. This difference between two rodent
species is intriguing and exhibits the complexity of the intracellular
regulation of gonocyte apoptosis. We show here in mouse that
TGFbeta2 is expressed in all the gonocytes during their quiescent
period. On the contrary, it is not expressed in rat quiescent gonocytes.
This species difference in TGFbeta expression pattern correlates withthe opposite role of TGFbeta on gonocyte development. The present
study suggests that the main regulation of mouse gonocytes by
TGFbeta is mediated by TGFbeta2, which acts as an autocrine factor.
By contrast, previous data suggest that gonocyte regulation in the rat
is mediated by TGFbeta1, acting as a paracrine factor produced by the
Leydig cells (Olaso et al., 1998). However, due to the Cre ectopic
action, we cannot completely exclude that TGFbeta signaling has been
inactivated in other cells or tissues regulating the testis function. In
the gonad, TβRII inactivation is likely only germ-speciﬁc as TNAP,
which targets the Cre excision, is not expressed in somatic cells
(MacGregor et al., 1995; Urven et al., 1993). Nevertheless, a TβRII
inactivation in the pituitary axis cannot be eliminated as no data have
been published about an eventual expression of TNAP in this tissue.
A correlation between the TGFbeta pathway inactivation in PGCs
and the impairment of adult spermatogenesis could be established.
The condKO males that survived until adulthood were primarily
fertile, but the older male, which was studied during 9 months,
became sterile from the age of 8 months. Histological analysis of testes
showed some depleted seminiferous tubules in the young adult and a
totally disorganized testis with atrophic tubules and no sperm in the
older one.
In condKO testes, some undifferentiated spermatogonia (SP/α6+/
c-Kit-/low) remain, but their number was reduced by around 35%
compared with WT testes. Moreover, the majority of these remaining
undifferentiated cells were quiescent (90-95% versus 70% in WT).
Despite the presence of undifferentiated spermatogonia in tubules,
these seemed unable to recover, since spermatogenesis is impaired.
This means that, either it doesn't remain stem cells among these
Fig. 7. The number of spermatogonial stem/immature progenitor cells and the proportion of cycling PLZF-positive cells are reduced in condKOmice. Using a Ho staining, the SP was
analyzed by ﬂow cytometry analysis in one 4-month-oldWT (A) and one 4-month-old condKO (C) mice during the same experiment. After gating the SP, theα6-integrin+/c-Kit-/low
and α6-integrin+/c-Kit+ populations were compared in WT (B) and condKO (D) animals. The number of PLZF-positive cells per 100 round tubule sections was counted in adult WT
and condKOmice after immunostaining (E). The proportion of PLZF+/Ki67+ cells was measured inWT and condKO testes, after double-immunostaining (F-G). PLZF+ cells appeared
in red (arrowheads), Ki67+ cells in green and PLZF+/Ki67+ cells in yellow (arrow).
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exhaustion could be explained differently: either (i) by a reduced pool
of stem cells in the young male, or (ii) by a stem cell hyper-
proliferation during their asymmetric division, associated with a
defect in their self-renewal.
Our ﬁrst hypothesis is that TGFbeta is involved in adult
spermatogenesis with an essential role in the maintenance of stem
cell capacity for self-renewal. Inactivation of the TGFbeta signaling
resulted in an early testis senescence due to a rapid stem cell
exhaustion. This is in agreement with ﬁndings about other members
of the TGFbeta family (such as Nodal or BMP4), which have been
reported to play important roles in the maintenance of self-renewal
and pluripotency of mouse ES cells (Watabe and Miyazono, 2009) (Qi
et al., 2004) or in germ stem cells (He et al., 2009).
A second hypothesis for this early sterility is that a defect in the
gonocyte-spermatogonia transition during neonatal life has led partly
to a reduced pool of stem cells in the young condKO adult. A quitesimilar phenotype of transitory fertility has been observed in mice
overexpressing the activin βA subunit (Tanimoto et al., 1999). In
addition, it has been reported that a decrease of the activin level is
necessary to the gonocyte-spermatogonia transition (Meehan et al.,
2000). Consequently, TGFbeta ligands, interacting with the activin
receptor, could induce the activin signaling pathway and mimic an
overexpression of activin leading to a defect in the gonocyte-
spermatogonia transition and ﬁnally to a lower pool of stem cells.
Thirdly, we can hypothesize that inactivation of TGFbeta signaling
could result in a hyper-proliferation of the differentiated progenitors
(A1 to B spermatogonia) in adult, leading to a rapid loss of these cells
and to an early sterility.
In conclusion, our present results demonstrate a direct and
physiological role of the TGFbeta signaling pathway in male germ cell
development.We showthatTGFbeta2 is anautocrinenegative regulator
of the proliferation and apoptosis of fetal and neonatal germ cells and
that the inactivation of the TGFbeta pathway does not completely
83S.G. Moreno et al. / Developmental Biology 342 (2010) 74–84prevent, but does reduce the gonocyte quiescent phase. Then, germ cell
regulation mediated by TGFbeta during testis development seems to be
important to initiate and maintain a normal adult spermatogenesis.
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